| pubmed-article:16510745 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16510745 | lifeskim:mentions | umls-concept:C0026769 | lld:lifeskim |
| pubmed-article:16510745 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
| pubmed-article:16510745 | lifeskim:mentions | umls-concept:C0254119 | lld:lifeskim |
| pubmed-article:16510745 | lifeskim:mentions | umls-concept:C1172734 | lld:lifeskim |
| pubmed-article:16510745 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:16510745 | pubmed:dateCreated | 2006-3-2 | lld:pubmed |
| pubmed-article:16510745 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16510745 | pubmed:abstractText | Interferon beta is used to modify the course of relapsing multiple sclerosis. Despite interferon beta therapy, many patients have relapses. Natalizumab, an alpha4 integrin antagonist, appeared to be safe and effective alone and when added to interferon beta-1a in preliminary studies. | lld:pubmed |
| pubmed-article:16510745 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16510745 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16510745 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16510745 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16510745 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16510745 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16510745 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16510745 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16510745 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16510745 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16510745 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16510745 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16510745 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16510745 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:16510745 | pubmed:issn | 1533-4406 | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:el-ZeinRR | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:GalettaSteven... | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:LublinFred... | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:SandrockAlfre... | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:Weinstock-Gut... | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:ConfavreuxChr... | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:CalabresiPete... | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:RudickRichard... | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:PanzaraMichae... | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:RadueErnst-Wi... | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:LynnFrancesF | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:WynnDaniel... | lld:pubmed |
| pubmed-article:16510745 | pubmed:author | pubmed-author:SENTINEL... | lld:pubmed |
| pubmed-article:16510745 | pubmed:copyrightInfo | Copyright 2006 Massachusetts Medical Society. | lld:pubmed |
| pubmed-article:16510745 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16510745 | pubmed:day | 2 | lld:pubmed |
| pubmed-article:16510745 | pubmed:volume | 354 | lld:pubmed |
| pubmed-article:16510745 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16510745 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16510745 | pubmed:pagination | 911-23 | lld:pubmed |
| pubmed-article:16510745 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:meshHeading | pubmed-meshheading:16510745... | lld:pubmed |
| pubmed-article:16510745 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16510745 | pubmed:articleTitle | Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. | lld:pubmed |
| pubmed-article:16510745 | pubmed:affiliation | Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. rudickr@ccf.org | lld:pubmed |
| pubmed-article:16510745 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16510745 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16510745 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16510745 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:16510745 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16510745 | lld:pubmed |
